205 related articles for article (PubMed ID: 18809654)
1. A polymer-type water-soluble peptidoglycan exhibited both Toll-like receptor 2- and NOD2-agonistic activities, resulting in synergistic activation of human monocytic cells.
Natsuka M; Uehara A; Yang S; Echigo S; Takada H
Innate Immun; 2008 Oct; 14(5):298-308. PubMed ID: 18809654
[TBL] [Abstract][Full Text] [Related]
2. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture.
Uehara A; Yang S; Fujimoto Y; Fukase K; Kusumoto S; Shibata K; Sugawara S; Takada H
Cell Microbiol; 2005 Jan; 7(1):53-61. PubMed ID: 15617523
[TBL] [Abstract][Full Text] [Related]
3. Chemically synthesized pathogen-associated molecular patterns increase the expression of peptidoglycan recognition proteins via toll-like receptors, NOD1 and NOD2 in human oral epithelial cells.
Uehara A; Sugawara Y; Kurata S; Fujimoto Y; Fukase K; Kusumoto S; Satta Y; Sasano T; Sugawara S; Takada H
Cell Microbiol; 2005 May; 7(5):675-86. PubMed ID: 15839897
[TBL] [Abstract][Full Text] [Related]
4. Chemical synthesis of peptidoglycan fragments for elucidation of the immunostimulating mechanism.
Fujimoto Y; Inamura S; Kawasaki A; Shiokawa Z; Shimoyama A; Hashimoto T; Kusumoto S; Fukase K
J Endotoxin Res; 2007; 13(3):189-96. PubMed ID: 17621561
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to proteinase 3 prime human monocytic cells via protease-activated receptor-2 and NF-kappaB for Toll-like receptor- and NOD-dependent activation.
Uehara A; Iwashiro A; Sato T; Yokota S; Takada H
Mol Immunol; 2007 Jul; 44(14):3552-62. PubMed ID: 17452051
[TBL] [Abstract][Full Text] [Related]
6. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists.
Fritz JH; Girardin SE; Fitting C; Werts C; Mengin-Lecreulx D; Caroff M; Cavaillon JM; Philpott DJ; Adib-Conquy M
Eur J Immunol; 2005 Aug; 35(8):2459-70. PubMed ID: 16021602
[TBL] [Abstract][Full Text] [Related]
7. Peptidoglycan and lipopolysaccharide synergistically enhance bone resorption and osteoclastogenesis.
Kishimoto T; Kaneko T; Ukai T; Yokoyama M; Ayon Haro R; Yoshinaga Y; Yoshimura A; Hara Y
J Periodontal Res; 2012 Aug; 47(4):446-54. PubMed ID: 22283724
[TBL] [Abstract][Full Text] [Related]
8. Natural Staphylococcus aureus-derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals.
Volz T; Nega M; Buschmann J; Kaesler S; Guenova E; Peschel A; Röcken M; Götz F; Biedermann T
FASEB J; 2010 Oct; 24(10):4089-102. PubMed ID: 20522786
[TBL] [Abstract][Full Text] [Related]
9. Expression of toll-like receptor 2, NOD2 and dectin-1 and stimulatory effects of their ligands and histamine in normal human keratinocytes.
Kobayashi M; Yoshiki R; Sakabe J; Kabashima K; Nakamura M; Tokura Y
Br J Dermatol; 2009 Feb; 160(2):297-304. PubMed ID: 19016710
[TBL] [Abstract][Full Text] [Related]
10. Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines.
Uehara A; Fujimoto Y; Fukase K; Takada H
Mol Immunol; 2007 May; 44(12):3100-11. PubMed ID: 17403538
[TBL] [Abstract][Full Text] [Related]
11. Butyrate mediates nucleotide-binding and oligomerisation domain (NOD) 2-dependent mucosal immune responses against peptidoglycan.
Leung CH; Lam W; Ma DL; Gullen EA; Cheng YC
Eur J Immunol; 2009 Dec; 39(12):3529-37. PubMed ID: 19830732
[TBL] [Abstract][Full Text] [Related]
12. Commercial peptidoglycan preparations are contaminated with superantigen-like activity that stimulates IL-17 production.
Li H; Nooh MM; Kotb M; Re F
J Leukoc Biol; 2008 Feb; 83(2):409-18. PubMed ID: 17991761
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of peptidoglycan fragments and evaluation of their biological activity.
Inamura S; Fujimoto Y; Kawasaki A; Shiokawa Z; Woelk E; Heine H; Lindner B; Inohara N; Kusumoto S; Fukase K
Org Biomol Chem; 2006 Jan; 4(2):232-42. PubMed ID: 16391765
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of TLR-mediated innate immune responses by peptidoglycans through NOD signaling.
Takada H; Uehara A
Curr Pharm Des; 2006; 12(32):4163-72. PubMed ID: 17100619
[TBL] [Abstract][Full Text] [Related]
15. Lactobacillus plantarum lipoteichoic acid down-regulated Shigella flexneri peptidoglycan-induced inflammation.
Kim HG; Lee SY; Kim NR; Lee HY; Ko MY; Jung BJ; Kim CM; Lee JM; Park JH; Han SH; Chung DK
Mol Immunol; 2011 Jan; 48(4):382-91. PubMed ID: 21129777
[TBL] [Abstract][Full Text] [Related]
16. Peptidoglycan and muramyl dipeptide from Staphylococcus aureus induce the expression of VEGF-A in human limbal fibroblasts with the participation of TLR2-NFκB and NOD2-EGFR.
Juárez-Verdayes MA; Rodríguez-Martínez S; Cancino-Diaz ME; Cancino-Diaz JC
Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):53-62. PubMed ID: 22890731
[TBL] [Abstract][Full Text] [Related]
17. A peptidoglycan monomer with the glutamine to serine change and basic peptides bind in silico to TLR-2 (403-455).
Li Y; Efferson CL; Ramesh R; Peoples GE; Hwu P; Ioannides CG
Cancer Immunol Immunother; 2011 Apr; 60(4):515-24. PubMed ID: 21188584
[TBL] [Abstract][Full Text] [Related]
18. The mu opioid receptor mediates morphine-induced tumor necrosis factor and interleukin-6 inhibition in toll-like receptor 2-stimulated monocytes.
Bonnet MP; Beloeil H; Benhamou D; Mazoit JX; Asehnoune K
Anesth Analg; 2008 Apr; 106(4):1142-9, table of contents. PubMed ID: 18349186
[TBL] [Abstract][Full Text] [Related]
19. The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype.
Borm ME; van Bodegraven AA; Mulder CJ; Kraal G; Bouma G
Genes Immun; 2008 Apr; 9(3):274-8. PubMed ID: 18340358
[TBL] [Abstract][Full Text] [Related]
20. A vitamin D3 analog augmented interleukin-8 production by human monocytic cells in response to various microbe-related synthetic ligands, especially NOD2 agonistic muramyldipeptide.
Ikeuchi T; Nakamura T; Fukumoto S; Takada H
Int Immunopharmacol; 2013 Jan; 15(1):15-22. PubMed ID: 23159604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
